Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions: A Report of 21 Cases and Review of the Literature

Online journal article in Hematopathology that offers 1.0 continuing education (CME/SAM) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

describe the clinicopathologic features of therapy-related chronic myeloid leukemia (CML) and how it differs from its de novo counterpart.
distinguish the...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

describe the clinicopathologic features of therapy-related chronic myeloid leukemia (CML) and how it differs from its de novo counterpart.
distinguish the cytogenetic profile of therapy-related CML from its de novo counterpart.
discuss hypothetical mechanisms or etiologies for the development of therapy-related CML.

View More View Less